Patrick B. Johnston

710 total citations
12 papers, 463 citations indexed

About

Patrick B. Johnston is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Patrick B. Johnston has authored 12 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 4 papers in Immunology. Recurrent topics in Patrick B. Johnston's work include CAR-T cell therapy research (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Patrick B. Johnston is often cited by papers focused on CAR-T cell therapy research (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Patrick B. Johnston collaborates with scholars based in United States, Japan and Sweden. Patrick B. Johnston's co-authors include Thomas M. Habermann, Ivana N. Micallef, Luis F. Porrata, David J. Inwards, Thomas E. Witzig, Betsy LaPlant, Craig B. Reeder, Candido E. Rivera, Carrie A. Thompson and Garth D. Nelson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Patrick B. Johnston

11 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick B. Johnston United States	5	400	279	203	117	83	12	463
Sietse Aukema Germany	9	568 1.4×	392 1.4×	324 1.6×	137 1.2×	92 1.1×	15	648
Stephen M. Ansell United States	7	302 0.8×	312 1.1×	150 0.7×	145 1.2×	46 0.6×	10	436
Kathryn Turner United Kingdom	2	358 0.9×	239 0.9×	195 1.0×	94 0.8×	76 0.9×	2	403
Junji Hiraga Japan	8	266 0.7×	185 0.7×	142 0.7×	91 0.8×	119 1.4×	17	464
Simon Rule United Kingdom	7	321 0.8×	242 0.9×	189 0.9×	38 0.3×	62 0.7×	12	390
Daniel Painter United Kingdom	7	253 0.6×	168 0.6×	143 0.7×	46 0.4×	73 0.9×	11	362
Fontanet Bijou France	11	234 0.6×	233 0.8×	217 1.1×	45 0.4×	117 1.4×	46	467
Manuela Arcamone Italy	8	283 0.7×	191 0.7×	108 0.5×	88 0.8×	25 0.3×	24	357
Armando López‐Guillermo Spain	7	307 0.8×	121 0.4×	247 1.2×	105 0.9×	23 0.3×	10	361
Vaishalee P. Kenkre United States	13	258 0.6×	260 0.9×	208 1.0×	30 0.3×	73 0.9×	37	456

Countries citing papers authored by Patrick B. Johnston

Since Specialization

Citations

This map shows the geographic impact of Patrick B. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick B. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick B. Johnston more than expected).

Fields of papers citing papers by Patrick B. Johnston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick B. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick B. Johnston. The network helps show where Patrick B. Johnston may publish in the future.

Co-authorship network of co-authors of Patrick B. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick B. Johnston. A scholar is included among the top collaborators of Patrick B. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick B. Johnston. Patrick B. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Assouline, Sarit, Amitkumar Mehta, Walter Hanel, et al.. (2025). Phase I/II Study of Subasumstat (TAK-981) in Combination With Rituximab in Relapsed/Refractory Non-Hodgkin Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 25(11). 788–799.e11. 1 indexed citations

Hwang, Steven R., Raphael Mwangi, Jason N. Barreto, et al.. (2025). Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience. Blood Advances. 9(4). 924–932. 6 indexed citations

Tun, Aung M., Yucai Wang, Seth Maliske, et al.. (2024). Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy. Transplantation and Cellular Therapy. 30(10). 1001.e1–1001.e12. 1 indexed citations

Tun, Aung M., Romil Patel, Alex Niu, et al.. (2024). Anti‐CD19 chimeric antigen receptor T‐cell therapy in older patients with relapsed or refractory large B‐cell lymphoma: A multicenter study. American Journal of Hematology. 99(9). 1712–1720. 4 indexed citations

Bansal, Radhika, Monica Shaw, Arushi Khurana, et al.. (2024). Real World Outcomes with Evolving Management of Cytokine Release Syndrome in CAR-T Therapy. Blood. 144(Supplement 1). 2274–2274. 1 indexed citations

Abramson, Jeremy S., Scott R. Solomon, Jon Arnason, et al.. (2024). Plain language summary of the TRANSFORM study primary analysis results: liso-cell as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen. Future Oncology. 20(21). 1455–1465. 1 indexed citations

Porrata, Luis F., Stephen M. Ansell, Ivana N. Micallef, et al.. (2024). Day 100 Recovery of Absolute Number of Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas. Biomedicines. 12(8). 1808–1808. 1 indexed citations

Martinez‐Thompson, Jennifer M., Rebecca L. King, William R. Macon, et al.. (2024). Neurologic Clinical, Electrophysiologic, and Pathologic Characteristics of Primary vs Secondary Neurolymphomatosis. Neurology. 103(6). e209777–e209777. 1 indexed citations

Ulrickson, Matthew L., Muhammad Husnain, Madiha Iqbal, et al.. (2023). Low Incidence of Fungal Infections after Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma in an Endemic Region for Coccidioidomycosis. Transplantation and Cellular Therapy. 29(2). S327–S328.

10.

Abramson, Jeremy S., Scott R. Solomon, Jon Arnason, et al.. (2022). Lisocabtagene Maraleucel (liso-cel) Versus Standard of Care (SOC) with Salvage Chemotherapy Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL): Primary Analysis of the Randomized, Phase 3 Transform Study. Blood. 140(Supplement 1). 1581–1583. 6 indexed citations

11.

Nowakowski, Grzegorz S., Betsy LaPlant, William R. Macon, et al.. (2014). Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study. Journal of Clinical Oncology. 33(3). 251–257. 268 indexed citations

12.

Johnston, Patrick B., David J. Inwards, Joseph P. Colgan, et al.. (2010). A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma. American Journal of Hematology. 85(5). 320–324. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact